DVA

#704
DaVita Inc. Common Stock
194.4 1 USD
-1.38%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
193.96
195.97
Intervallo Annuale
101.00
202.58
Variazione giornaliera
-1.38%
Variazione Mensile
+28.82%
Variazione di 6 mesi
+63.00%
Variazione Annuale
+43.39%
Chiusura Precedente
197.1 4
Open
195.9 7
Minimo
193.9 6
High
195.9 7
Volume
385
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

DaVita Inc. Common Stock

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

Notizie